Multifaceted Nature of Female Sexual Dysfunction: Diagnosis, Causes, and Comprehensive Care

Психотерапия
Ольга
Ольга Боярчук
31 июля 2026

Article narration

Loading…
Multifaceted Nature of Female Sexual Dysfunction: Diagnosis, Causes, and Comprehensive Care

The multifaceted nature of female sexual dysfunction: diagnosis, causes, and comprehensive care

Sexuality is a natural part of life. Women at various stages of life, including reproductive age, may encounter sexual problems, which negatively impact their health and emotional well-being. Female sexual dysfunction, in general, is a complex and under-researched condition that can be caused by various physiological, hormonal, psychological, and social factors.

According to the World Health Organization, sexual health is a state of physical, emotional, mental, and social well-being in relation to sexuality; it is not merely the absence of disease, dysfunction, or infirmity.

According to the «Diagnostic and Statistical Manual of Mental Disorders» (DSM-5-TR), female sexual dysfunction is defined as any dissatisfaction in areas of sexual function such as sexual interest/arousal disorder, orgasmic disorders, and genito-pelvic pain/penetration disorder, which results in significant sexual distress.

Diagnostic Criteria

For the diagnosis of sexual dysfunction in women, 3 of the following 6 symptoms must be present for at least 6 months and cause clinically significant distress:

  • Absent or reduced interest in sexual activity.
  • Absent or reduced sexual or erotic thoughts or fantasies.
  • Absent or reduced sexual activity and/or receptivity to partner's initiation.
  • Absent or reduced sexual arousal or pleasure during sexual activity in all or almost all cases (75% to 100% of sexual encounters).
  • Absent or reduced sexual interest or arousal in response to any internal or external sexual or erotic stimuli or cues.
  • Absent or reduced genital or non-genital sensations during sexual activity in almost all (75% to 100%) sexual encounters.

Sexual Dysfunction and Hormonal Balance

Dick Swaab, a prominent neurobiologist, states that hormones are involved in all aspects of sexual behavior. Testosterone, a male sex hormone, affects the development of desire not only in men but also in women. Sex hormones, including progesterone and estrogen, also regulate sexual desire and sexuality in women by interacting with various neurotransmitters, thereby controlling sexual drive and pleasure from sex.

Some neurotransmitters are responsible for excitatory pathways, which are primarily controlled by dopaminergic substances, including dopamine and norepinephrine. Dopamine enhances sexual arousal and desire, while norepinephrine enhances arousal and orgasm. Inhibitory pathways affecting sexual desire and pleasure are mainly associated with the serotonergic system. Excessive serotonin release or reduced serotonin metabolism can lead to a loss of libido and decreased sexual desire or arousal. Selective serotonin reuptake inhibitors (antidepressants) can cause symptoms similar to those observed in attention deficit hyperactivity disorder, due to increased serotonin levels. Another pathophysiological factor can be hormone deficiency: a decrease in estrogen levels associated with menopause can lead to reduced sexual desire and atrophy of genital tissues, making sexual intercourse painful.

Causes of Occurrence

Physiological and Medical Factors:

  • Age, developmental stages, and reproductive stages (pregnancy, abortions, childbirth, premenopause, menopause, and postmenopause).
  • Anatomical features, injuries, genital atrophy, traumatic surgeries on female reproductive organs, and chronic diseases (including pelvic floor disorders).
  • Hormonal imbalances, such as estrogen deficiency or thyroid problems.
  • Chronic fatigue, sleep disturbances, and poor nutrition.
  • Premature sexual intercourse without preparation (insufficient or absent vaginal lubrication).
  • General diseases, including diabetes, liver diseases, malignant tumors, cardiorespiratory disorders, neurological diseases, and urinary tract dysfunction.
  • Taking specific medications (oral contraceptives, antidepressants, antibiotics, etc.).
  • Overweight and smoking.

Psychological Factors:

  • Couple problems: new relationships, unresolved conflicts, constant quarrels, infidelity, crises, attempts to avoid contact, or dissatisfaction with a partner's sexual abilities.
  • Mental illnesses, including comorbid (co-occurring) ones: affective and/or anxiety disorders, panic attacks, depression, phobias, or bipolar disorder.
  • Inability to openly discuss preferences and desires, fear of rejection.
  • Shame caused by «wrong» desires and needs, as well as rigid introjects («a decent woman should not...»).
  • Body image disturbance, self-rejection, and low self-esteem.
  • Lack of sex education and positive sexual experience.
  • Traumatic experiences (e.g., painful loss of virginity), past abuse, incest, or tendency to self-harm.

Sociocultural Factors:

  • Upbringing (strict family, regional and religious characteristics).
  • Lack of normal living conditions (e.g., living with parents) or low income.
  • Current stressful life situations (job loss, work problems, having young children, caring for elderly parents, relocation, etc.).

Key Components of Female Sexual Dysfunction

“Female sexual dysfunction” is a general term for a complex set of problems. Let's look more specifically at the most common symptoms:

  • Dyspareunia. DSM-5-TR defines it as marked pain during intercourse or attempted vaginal penetration, tension of vaginal muscles with decreased ability for penetration, feelings of tension, pain, or burning upon attempted penetration, and decreased or absent desire to engage in intercourse, leading to avoidance of sexual activity or strong fear of pain. The most common symptoms reported by patients are localized or deep pelvic pain during or after intercourse, increased muscle tension in the pelvic floor area, and tenderness on palpation of the vaginal vestibule, lateral vaginal walls, or pelvic musculature. The condition is primarily caused by physical or medical factors and is also often associated with a history of sexual abuse. Treatment for dyspareunia involves addressing underlying causes and pain management.
  • Vaginismus. Defined as “recurrent or persistent involuntary spasm of the musculature of the outer third of the vagina, which interferes with intercourse and causes discomfort and difficulties in interpersonal relationships.” Since these two diagnoses are combined, there is often confusion in diagnosis. Unlike dyspareunia, vaginismus is primarily caused by psychological factors and is closely linked to both sexual and emotional abuse. Treatment for vaginismus focuses on alleviating fear and pelvic floor muscle spasms. Primary vaginismus during first intercourse is also a common problem, often diagnosed in adolescent girls and women under 25; here, vaginismus often has a psychological basis – fear of penetration, insufficient stimulation due to lack of experience, strict upbringing.
  • Anorgasmia (Orgasmic Dysfunction). Defined as the absence, delay, rarity, or significant reduction in orgasm intensity in at least 75% of sexual activity. The following subtypes are distinguished: lifelong or acquired, generalized or situational, absence of orgasm in the past, and mild, moderate, or severe forms. Older classifications distinguished between “primary anorgasmia” (lifelong absence of orgasm) and “secondary anorgasmia” (acquired or situational). Absence of orgasm or difficulty achieving it is common. It is worth noting that not all women who have difficulty achieving orgasm experience distress, so the prevalence of the problem is higher than the number of diagnosed cases.
  • Sexual Aversion. In the DSM-IV-TR classification, it was defined as recurrent or persistent extreme avoidance of or aversion to all or almost all genital sexual contact with a sexual partner (although the diagnosis was excluded from DSM-5-TR, it remains a frequent request in psychotherapy). Sexual aversion is considered a phobic reaction to contact and in many ways resembles an anxiety disorder more than a sexual one. It often reaches catastrophic proportions when a woman (or man) avoids any physical contact for fear it might lead to sexual interaction. Little is known about the etiology of this condition, other than that individuals experience intense anxiety in anticipation of potential contact. Aversion is not always related to the sexual act itself; it can be directed at specific sexual elements and may strengthen or weaken over time.

Comprehensive Assistance

In most cases, treatment for female sexual arousal disorder involves a combination of psychotherapy and pharmacotherapy. The first step in treating sexual dysfunction should be an in-person consultation with a gynecologist. This includes basic patient education on sexuality and recommendations for lifestyle changes to improve sexual drive, interest, and sensation. It is also necessary to undergo tests (primarily hormonal) to understand the clinical picture.

Since problems in sexual life very often arise due to various psychological difficulties, psychotherapy will be a good addition to medication. The Gestalt approach, for example, pays much attention to embodiment, self-awareness, and one's boundaries, and also works very gently with trauma of violence and incest, fears, neuroses, and relationship problems using various exercises and techniques.

Since sexual disorder is a very delicate and often taboo topic, great courage and inner strength are needed to ask for help. If you recognize your symptoms in this article, I invite you to an introductory session: together we will voice the problem and outline a possible path of therapy that will help you regain contact with your body, pleasure from interaction with your partner, and a full sexual life without fears and difficulties.

Conclusion

Female sexual dysfunction is a multifactorial problem that requires a gentle and comprehensive approach. Its successful treatment is impossible without considering the close interaction of physiological, hormonal, psychological, and sociocultural aspects. Timely diagnosis, overcoming feelings of shame, and openly seeking help from relevant specialists (gynecologists, endocrinologists, and psychotherapists) help women address internal barriers, cope with distress, and restore harmony in their sexual and emotional lives.

From the Editors:

As visual accompaniment to Olga Boyarchuk's article, we chose the painting "Black Iris" (1926) by the famous American artist Georgia O'Keeffe. The editors' choice is justified by the deep metaphorical similarity between O'Keeffe's refined language of painting and the intrinsic nature of female sexuality. The artist's canvases with macro images of flowers are traditionally interpreted in world art as a sophisticated exploration of female anatomy, corporeality, and sensuality. The complex, delicate curves, multi-layered petals, and deep, hidden dark tones of "Black Iris" flawlessly reflect the very essence of the text: women's sexual health is not a straightforward mechanism, but the most delicate, multifactorial system where biological layers intertwine with profound psychological and sociocultural processes. The closed, self-protecting buds and shadows hidden within the petals symbolize the very barriers, fears, introjects, and dysfunctions that women encounter. This painting reminds researchers and practicing therapists that questions of female somatics and sexuality must be approached with utmost respect, care, and a willingness to explore the internal architectonics hidden from superficial views.

References:

  1. World Health Organization. Sexual and Reproductive Health and Research (SRH). Including the Human Reproduction Special Programme (HRP).
  2. Diagnostic and Statistical Manual of mental disorders, fifth edition (DSM-5-TR).
  3. Adebisi OY, Carlson K. Female Sexual Interest and Arousal Disorder. [Updated 2024 Oct 29].
  4. Swaab D. We Are Our Brains: From the Womb to Alzheimer's. — M.: Azbuka-Atticus, 2014.
  5. Barth C, Villringer A, Sacher J. Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci. 2015;9:37.
  6. Pachano Pesantez GS, Clayton AH. Treatment of Hypoactive Sexual Desire Disorder Among Women: General Considerations and Pharmacological Options. Focus (Am Psychiatr Publ). 2021 Jan;19(1):39-45.
  7. Rappek NAM, Sidi H, Kumar J, Kamarazaman S, Das S, Masiran R, Baharuddin N, Hatta MH. Serotonin Selective Reuptake Inhibitors (SSRIs) and Female Sexual Dysfunction (FSD): Hypothesis on its Association and Options of Treatment. Curr Drug Targets. 2018;19(12):1352-1358.
  • American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol. 2019 Jul. 134 (1):e1-e18.
  • Carlson K, Mikes BA. Dyspareunia. [Updated 2026 Jan 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
  • Raveendran AV, Rajini P. Vaginismus: Diagnostic Challenges and Proposed Diagnostic Criteria. Balkan Med J. 2024 Jan 3;41(1):80-82.
  • Marchand E. Psychological and Behavioral Treatment of Female Orgasmic Disorder. Sexual Medicine Reviews, Volume 9, Issue 2, 2021. P. 194-211.
  • J Kiesner, C Bittoni, SEXUAL AVERSION AMONG FEMALES: TRAIT-LIKE STABILITY AND DAY-TO-DAY CHANGES IN RELATION TO PHYSICAL SYMPTOMS, PSYCHOLOGICAL SYMPTOMS, AND OTHER ASPECTS OF SEXUAL FUNCTION, The Journal of Sexual Medicine, Volume 22, Issue Supplement_2, May 2025, qdaf077.028.
  •  

    Онлайн-психотерапияГештальт-терапияОльга БоярчукНасилиеТравмаСтыдсексуальная дисфункцияженское здоровьесексуальностьЖенская сексуальностьЖенская сексуальная дисфункцияАноргазмияВагинизмЖенская травмаДиспареунияГормональный фонproEgo
    Views: 387

    Комментарии аккредитованных экспертов (0)

    Войдите, чтобы оставлять комментарии

    Пока нет комментариев. Будьте первым!